One hundred forty-three non-diabetic adult RA patients ( @ % female , age @ @ -LSB- mean SD -RSB- ) on stable RA standard of care treatment were enrolled in a randomized , double-blind placebo controlled crossover trial of @ mg daily pioglitazone versus placebo , with a @-month duration/arm and a @-month washout period .